Idexx Laboratories (IDXX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Idexx Laboratories (IDXX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.80% |
| Mar 31, 2026 | 6.39% |
| Dec 31, 2025 | 7.24% |
| Sep 30, 2025 | 13.42% |
| Jun 30, 2025 | 14.56% |
| Mar 31, 2025 | 16.75% |
| Dec 31, 2024 | 19.01% |
| Sep 30, 2024 | 16.43% |
| Jun 30, 2024 | 10.09% |
| Mar 31, 2024 | 18.06% |
| Dec 31, 2023 | 17.82% |
| Sep 30, 2023 | 17.89% |
| Jun 30, 2023 | 15.59% |
| Mar 31, 2023 | 19.06% |
| Dec 31, 2022 | 35.08% |
| Sep 30, 2022 | 20.74% |
| Jun 30, 2022 | 9.09% |
| Mar 31, 2022 | 22.94% |
| Dec 31, 2021 | 25.46% |
| Sep 30, 2021 | 25.42% |